Alcon Net Income 2019-2024 | ALC
Alcon annual/quarterly net income history and growth rate from 2019 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Alcon net income for the quarter ending December 31, 2024 was $284M, a 33.49% decline year-over-year.
- Alcon net income for the twelve months ending December 31, 2024 was $1.018B, a 4.52% increase year-over-year.
- Alcon annual net income for 2024 was $1.018B, a 4.52% increase from 2023.
- Alcon annual net income for 2023 was $0.974B, a 190.75% increase from 2022.
- Alcon annual net income for 2022 was $0.335B, a 10.9% decline from 2021.
| Alcon Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $1,018 |
| 2023 | $974 |
| 2022 | $335 |
| 2021 | $376 |
| 2020 | $-531 |
| 2019 | $-656 |
| 2018 | $-227 |
| Alcon Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $284 |
| 2024-09-30 | $263 |
| 2024-06-30 | $223 |
| 2024-03-31 | $248 |
| 2023-12-31 | $427 |
| 2023-09-30 | $204 |
| 2023-06-30 | $169 |
| 2023-03-31 | $174 |
| 2022-12-31 | $-97 |
| 2022-09-30 | $116 |
| 2022-06-30 | $148 |
| 2022-03-31 | $168 |
| 2021-12-31 | $139 |
| 2021-09-30 | $2 |
| 2021-06-30 | $151 |
| 2021-03-31 | $84 |
| 2020-12-31 | $95 |
| 2020-09-30 | $-147 |
| 2020-06-30 | $-422 |
| 2020-03-31 | $-57 |
| 2019-12-31 | $-91 |
| 2019-09-30 | $-66 |
| 2019-06-30 | $-390 |
| 2019-03-31 | $-109 |
| 2018-12-31 | |
| 2018-09-30 | $-207 |
| 2018-06-30 | $15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $45.645B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $171.942B | 78.88 |
| Thermo Fisher Scientific (TMO) | United States | $161.378B | 19.56 |
| Edwards Lifesciences (EW) | United States | $42.050B | 27.30 |
| IDEXX Laboratories (IDXX) | United States | $33.347B | 38.56 |
| DexCom (DXCM) | United States | $26.887B | 41.56 |
| IQVIA Holdings (IQV) | United States | $25.374B | 14.04 |
| STERIS (STE) | Ireland | $21.834B | 24.97 |
| Mettler-Toledo (MTD) | United States | $20.944B | 24.42 |
| Waters (WAT) | United States | $19.099B | 27.04 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.304B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.878B | 14.16 |
| Hologic (HOLX) | United States | $12.916B | 13.94 |
| Sysmex ADR (SSMXY) | Japan | $11.847B | 0.00 |
| Penumbra (PEN) | United States | $10.729B | 96.64 |
| Globus Medical (GMED) | United States | $9.767B | 22.61 |
| Masimo (MASI) | United States | $8.221B | 34.50 |
| Teleflex (TFX) | United States | $6.004B | 9.24 |
| Glaukos (GKOS) | United States | $5.153B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.081B | 22.07 |
| TransMedics (TMDX) | United States | $2.985B | 87.37 |
| PROCEPT BioRobotics (PRCT) | United States | $2.907B | 0.00 |
| Veracyte (VCYT) | United States | $2.427B | 43.86 |
| Nihon Kohden (NHNKY) | Japan | $2.081B | 11.37 |
| LivaNova (LIVN) | United Kingdom | $1.934B | 11.74 |
| Elekta AB (EKTAY) | Sweden | $1.891B | 17.00 |
| Alphatec Holdings (ATEC) | United States | $1.522B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.18 |
| Pulse Biosciences (PLSE) | United States | $1.193B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Paragon 28 (FNA) | United States | $1.099B | 0.00 |
| Artivion (AORT) | United States | $0.979B | 91.72 |
| OPKO Health (OPK) | United States | $0.954B | 0.00 |
| AxoGen (AXGN) | United States | $0.690B | 0.00 |
| IRadimed (IRMD) | United States | $0.658B | 34.51 |
| Mesa Laboratories (MLAB) | United States | $0.609B | 13.30 |
| SiBone (SIBN) | United States | $0.588B | 0.00 |
| RxSight (RXST) | United States | $0.584B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 9.21 |
| OrthoPediatrics (KIDS) | United States | $0.510B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.508B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.483B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.406B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.351B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.342B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.315B | 16.87 |
| Semler Scientific (SMLR) | United States | $0.312B | 6.62 |
| Neuronetics (STIM) | United States | $0.247B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.181B | 0.00 |
| 908 Devices (MASS) | United States | $0.168B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.152B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.110B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.104B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.104B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |